Novavax, Inc. - Common Stock (NQ:NVAX)

10.46 -0.14 (-1.32%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

68 69 Next >

3 Overrated Stocks We Approach with Caution

October 02, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...

Via StockStory

3 Volatile Stocks with Questionable Fundamentals

September 21, 2026

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability ...

Via StockStory

Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know

September 15, 2026

What Happened? A number of stocks fell in the morning session after bipartisan lawmakers introduced the Protecting Approved Care Act, legislation aimed at re...

Via StockStory

Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know

September 11, 2026

What Happened? A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broader equity ma...

Via StockStory

Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot ↗

September 10, 2026

Novavax (NASDAQ:NVAX) executives outlined the company’s transition from a COVID-19 vaccine-focused business toward a partnership-driven model centered on its Matrix-M adjuvant technology, with...

Via MarketBeat

Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference ↗

September 10, 2026

Novavax (NASDAQ:NVAX) outlined its strategy to expand the use of its Matrix-M adjuvant platform through licensing partnerships, internal research programs and commercialization alliances, with...

Via MarketBeat

3 Russell 2000 Stocks We’re Skeptical Of

September 10, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...

Via StockStory

3 of Wall Street’s Favorite Stocks with Open Questions

September 09, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

September 03, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...

Via StockStory

Unpacking Q2 Earnings: Novavax (NASDAQ:NVAX) In The Context Of Other Therapeutics Stocks

August 25, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how therapeutics stocks fa...

Via StockStory

Topics Artificial Intelligence

Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical

August 21, 2026

Check out the companies making headlines this week: Bally's (NYSE:BALY): Gaming, betting and entertainment company Bally's Corporation (NYSE:BALY) rose by 11...

Via StockStory

Topics Artificial Intelligence

3 Unprofitable Stocks Walking a Fine Line

August 21, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

Novavax (NVAX) Shares Skyrocket, What You Need To Know

August 19, 2026

What Happened? Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 6.9% in the afternoon session after positive trial results from peers Mod...

Via StockStory

Novavax Stock Moves Higher Wednesday: What's Driving the Action? ↗

August 19, 2026

Shares of Novavax Inc (NASDAQ: NVAX) are trading higher Wednesday. The move comes as a major clinical victory in the oncology space generated widespread momentum across vaccine developers.

Via Benzinga

Novavax Q2 Earnings Call Highlights ↗

August 07, 2026

Novavax (NASDAQ:NVAX) reported second-quarter 2026 revenue of $57 million and a net loss of $53 million, while highlighting progress in its Sanofi partnership, expanding use of its Matrix-M adjuvant...

Via MarketBeat

Topics Earnings

Novavax (NASDAQ:NVAX) Exceeds Q2 CY2026 Expectations

August 06, 2026

Vaccine biotechnology company Novavax (NASDAQ:NVAX) announced better-than-expected revenue in Q2 CY2026, but sales fell by 76.3% year on year to $56.7 millio...

Via StockStory

What To Expect From Novavax’s (NVAX) Q2 Earnings

August 04, 2026

Vaccine biotechnology company Novavax (NASDAQ:NVAX) will be reporting results this Thursday before the bell. Here’s what you need to know. Novavax beat analy...

Via StockStory

Topics Artificial Intelligence

Q1 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks

July 26, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a...

Via StockStory

Topics Artificial Intelligence

Therapeutics Stocks Q1 Highlights: Moderna (NASDAQ:MRNA)

July 23, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Moderna (NASDAQ:MRNA) and its...

Via StockStory

Topics Artificial Intelligence

1 of Wall Street’s Favorite Stocks to Keep an Eye On and 2 That Underwhelm

July 21, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

1 Cash-Heavy Stock on Our Buy List and 2 That Underwhelm

July 14, 2026

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...

Via StockStory

Topics Economy Supply Chain

1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down

July 02, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...

Via StockStory

A Look Back at Therapeutics Stocks’ Q1 Earnings: Novavax (NASDAQ:NVAX) Vs The Rest Of The Pack

June 15, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Novav...

Via StockStory

Topics Artificial Intelligence

3 Cash-Burning Stocks We Think Twice About

June 04, 2026

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sh...

Via StockStory

Why Novavax (NVAX) Stock Is Trading Up Today

May 26, 2026

What Happened? Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 11.3% in the afternoon session after documents revealed that advisers to ...

Via StockStory

Topics Artificial Intelligence Economy

3 Reasons NVAX is Risky and 1 Stock to Buy Instead

May 25, 2026

Novavax has had an impressive run over the past six months as its shares have beaten the S&P 500 by 27.6%. The stock now trades at $9.21, marking a 37.6% gai...

Via StockStory

Topics Stocks

3 Small-Cap Stocks That Fall Short

May 14, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Via StockStory

Topics Energy

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗

May 13, 2026

Investors can find much better opportunities.

Via The Motley Fool

GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know

May 13, 2026

What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...

Via StockStory

Topics Economy

The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call

May 13, 2026

Novavax delivered first quarter results that surpassed Wall Street’s revenue and earnings estimates, leading to a significant positive market reaction. Manag...

Via StockStory

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.